Our customers in the pharmaceutical industry all agree:
In vivo imaging during the drug development process can drastically reduce time and costs.
Imaging in preclinical research requires excellent quantitative reproducibility and low X-ray dose. At SCANCO Medical both of these requirements are central in our design and development of cutting-edge in vivo microCT systems.
vivaCT 40 and vivaCT 75 deliver outstanding high-resolution in vivo images. Fast scan times and an innovative design minimize the X-ray dose, allowing repeated scanning of individuals during a study. Field-of-view can be varied mechanically, increasing resolution for smaller scan sizes without affecting scan time. Real-time control of scanning in response to physiological events such as respiration is supported by an optional monitoring and gating unit.
XtremeCT, originally designed for clinical research, is an exceptionally versatile tool for preclinical studies that require a large field-of-view.
Preclinical systems | vivaCT 40 | vivaCT 75 | XtremeCT |
|
|
| |
Peak energy | 30 - 70 kVp | 30 - 70 kVp | 60 kVp |
Max. scan size | 38 x 145 mm (ØxL) | 78 x 145 mm (ØxL) | 126 x 150 or 240* mm (ØxL) |
Max. specimen size* | 80 x 500 mm (ØxL) | 80 x 500 mm (ØxL) | 128 mm (Ø) |
Best resolution (nominal) | 10 µm | 20 µm | 41 µm |
Best resolution (10% MTF) | ‹ 16 µm | ‹ 36 µm | ‹ 105 µm |
*See scanner specifications for details